Which has stronger earnings & valuation, LFWD or NRXS?

NeurAxis has lower revenue, but higher earnings than Lifeward. NeurAxis is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lifeward $20.92M 0.99 -$19.91M -$19.66 N/A NeurAxis $4.28M 19.79 -$14.63M -$0.81 N/A

Is LFWD or NRXS more profitable?

Lifeward has a net margin of -123.66% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Lifeward -123.66% -243.14% -97.39% NeurAxis -492.76% N/A -641.25%

Does the media prefer LFWD or NRXS?

In the previous week, Lifeward and Lifeward both had 2 articles in the media. Lifeward's average media sentiment score of 2.00 beat NeurAxis' score of 0.99 indicating that Lifeward is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifeward 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive NeurAxis 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, LNSR or LFWD?

Lifeward has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LENSAR $58.44M 1.23 -$34.28M -$0.58 N/A Lifeward $20.92M 0.99 -$19.91M -$19.66 N/A

Is LNSR or LFWD more profitable?

LENSAR has a net margin of 50.94% compared to Lifeward's net margin of -123.66%. LENSAR's return on equity of -183.19% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets LENSAR 50.94% -183.19% 42.26% Lifeward -123.66% -243.14% -97.39%

Does the media prefer LNSR or LFWD?

In the previous week, LENSAR and LENSAR both had 2 articles in the media. Lifeward's average media sentiment score of 2.00 beat LENSAR's score of 0.00 indicating that Lifeward is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LENSAR 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lifeward 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger earnings and valuation, NNOX or LFWD?

Lifeward has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nano-X Imaging $13.02M 5.35 -$75.02M -$1.58 N/A Lifeward $20.92M 0.99 -$19.91M -$19.66 N/A

Is NNOX or LFWD more profitable?

Lifeward has a net margin of -123.66% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Nano-X Imaging -716.44% -70.96% -62.26% Lifeward -123.66% -243.14% -97.39%

Does the media prefer NNOX or LFWD?

In the previous week, Nano-X Imaging had 22 more articles in the media than Lifeward. MarketBeat recorded 24 mentions for Nano-X Imaging and 2 mentions for Lifeward. Lifeward's average media sentiment score of 2.00 beat Nano-X Imaging's score of 0.20 indicating that Lifeward is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 1 Very Positive mention(s) 1 Positive mention(s) 22 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lifeward 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts prefer DXR or LFWD?

Lifeward has a consensus target price of $10.00, suggesting a potential upside of 35.70%. Given Lifeward's higher possible upside, analysts plainly believe Lifeward is more favorable than Daxor. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Lifeward 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, DXR or LFWD?

Daxor has higher earnings, but lower revenue than Lifeward. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Daxor N/A N/A N/A N/A N/A Lifeward $20.92M 0.99 -$19.91M -$19.66 N/A

Is DXR or LFWD more profitable?

Daxor has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Daxor's return on equity of 0.00% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Daxor N/A N/A N/A Lifeward -123.66% -243.14% -97.39%

Does the media prefer DXR or LFWD?

In the previous week, Daxor had 1 more articles in the media than Lifeward. MarketBeat recorded 3 mentions for Daxor and 2 mentions for Lifeward. Lifeward's average media sentiment score of 2.00 beat Daxor's score of 0.67 indicating that Lifeward is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Daxor 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lifeward 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts recommend LFWD or SKYA?

Lifeward presently has a consensus target price of $10.00, suggesting a potential upside of 35.70%. Given Lifeward's stronger consensus rating and higher probable upside, analysts plainly believe Lifeward is more favorable than SkyAI, Inc. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifeward 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SkyAI, Inc. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Lifeward (LFWD) Competitors

$7.37 +0.16 (+2.21%)

Closing price 03:58 PM Eastern

Extended Trading

$7.32 -0.05 (-0.73%)

As of 04:10 PM Eastern

Compare

LFWD vs. NRXS, LNSR, NNOX, DXR, and SKYA

Should you buy Lifeward stock or one of its competitors? MarketBeat compares Lifeward with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Lifeward include NeurAxis (NRXS), LENSAR (LNSR), Nano-X Imaging (NNOX), Daxor (DXR), and SkyAI, Inc. Common Stock (SKYA).

How does Lifeward compare to NeurAxis?

Lifeward (NASDAQ:LFWD) and NeurAxis (NASDAQ:NRXS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation.

26.8% of Lifeward shares are owned by institutional investors. Comparatively, 11.8% of NeurAxis shares are owned by institutional investors. 1.5% of Lifeward shares are owned by company insiders. Comparatively, 21.1% of NeurAxis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Lifeward and Lifeward both had 2 articles in the media. Lifeward's average media sentiment score of 2.00 beat NeurAxis' score of 0.99 indicating that Lifeward is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lifeward	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
NeurAxis	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeurAxis has lower revenue, but higher earnings than Lifeward. NeurAxis is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$20.92M	0.99	-$19.91M	-$19.66	N/A
NeurAxis	$4.28M	19.79	-$14.63M	-$0.81	N/A

Lifeward currently has a consensus target price of $10.00, indicating a potential upside of 35.70%. NeurAxis has a consensus target price of $13.00, indicating a potential upside of 91.46%. Given NeurAxis' stronger consensus rating and higher possible upside, analysts plainly believe NeurAxis is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
NeurAxis	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Lifeward has a net margin of -123.66% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-123.66%	-243.14%	-97.39%
NeurAxis	-492.76%	N/A	-641.25%

Lifeward has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market. Comparatively, NeurAxis has a beta of 1.43, indicating that its share price is 43% more volatile than the broader market.

Summary

NeurAxis beats Lifeward on 8 of the 14 factors compared between the two stocks.

How does Lifeward compare to LENSAR?

LENSAR (NASDAQ:LNSR) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

LENSAR currently has a consensus target price of $10.00, suggesting a potential upside of 71.53%. Lifeward has a consensus target price of $10.00, suggesting a potential upside of 35.70%. Given LENSAR's stronger consensus rating and higher possible upside, equities research analysts plainly believe LENSAR is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Lifeward	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, LENSAR and LENSAR both had 2 articles in the media. Lifeward's average media sentiment score of 2.00 beat LENSAR's score of 0.00 indicating that Lifeward is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LENSAR	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lifeward	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

LENSAR has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, Lifeward has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market.

LENSAR has a net margin of 50.94% compared to Lifeward's net margin of -123.66%. LENSAR's return on equity of -183.19% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LENSAR	50.94%	-183.19%	42.26%
Lifeward	-123.66%	-243.14%	-97.39%

Lifeward has lower revenue, but higher earnings than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LENSAR	$58.44M	1.23	-$34.28M	-$0.58	N/A
Lifeward	$20.92M	0.99	-$19.91M	-$19.66	N/A

40.2% of LENSAR shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 65.8% of LENSAR shares are held by insiders. Comparatively, 1.5% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

LENSAR beats Lifeward on 12 of the 15 factors compared between the two stocks.

How does Lifeward compare to Nano-X Imaging?

Nano-X Imaging (NASDAQ:NNOX) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

Lifeward has a net margin of -123.66% compared to Nano-X Imaging's net margin of -716.44%. Nano-X Imaging's return on equity of -70.96% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-716.44%	-70.96%	-62.26%
Lifeward	-123.66%	-243.14%	-97.39%

Nano-X Imaging presently has a consensus target price of $4.00, suggesting a potential upside of 300.00%. Lifeward has a consensus target price of $10.00, suggesting a potential upside of 35.70%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than Lifeward.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.67
Lifeward	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 1.5% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Lifeward has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	5.35	-$75.02M	-$1.58	N/A
Lifeward	$20.92M	0.99	-$19.91M	-$19.66	N/A

In the previous week, Nano-X Imaging had 22 more articles in the media than Lifeward. MarketBeat recorded 24 mentions for Nano-X Imaging and 2 mentions for Lifeward. Lifeward's average media sentiment score of 2.00 beat Nano-X Imaging's score of 0.20 indicating that Lifeward is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	1 Very Positive mention(s)	1 Positive mention(s)	22 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lifeward	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Nano-X Imaging has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.38, suggesting that its share price is 62% less volatile than the broader market.

Summary

Nano-X Imaging beats Lifeward on 9 of the 16 factors compared between the two stocks.

How does Lifeward compare to Daxor?

Daxor (NASDAQ:DXR) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

Lifeward has a consensus target price of $10.00, suggesting a potential upside of 35.70%. Given Lifeward's higher possible upside, analysts plainly believe Lifeward is more favorable than Daxor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Lifeward	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Daxor had 1 more articles in the media than Lifeward. MarketBeat recorded 3 mentions for Daxor and 2 mentions for Lifeward. Lifeward's average media sentiment score of 2.00 beat Daxor's score of 0.67 indicating that Lifeward is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Daxor	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lifeward	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Daxor has a beta of 0.27, indicating that its stock price is 73% less volatile than the broader market. Comparatively, Lifeward has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market.

1.3% of Daxor shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 51.5% of Daxor shares are held by insiders. Comparatively, 1.5% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Daxor has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. Daxor's return on equity of 0.00% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Lifeward	-123.66%	-243.14%	-97.39%

Daxor has higher earnings, but lower revenue than Lifeward.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	N/A	N/A	N/A	N/A	N/A
Lifeward	$20.92M	0.99	-$19.91M	-$19.66	N/A

Summary

Daxor beats Lifeward on 6 of the 11 factors compared between the two stocks.

How does Lifeward compare to SkyAI, Inc. Common Stock?

Lifeward (NASDAQ:LFWD) and SkyAI, Inc. Common Stock (NASDAQ:SKYA) are related small-cap companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

SkyAI, Inc. Common Stock has a net margin of 0.00% compared to Lifeward's net margin of -123.66%. SkyAI, Inc. Common Stock's return on equity of -157.91% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lifeward	-123.66%	-243.14%	-97.39%
SkyAI, Inc. Common Stock	N/A	-157.91%	-154.40%

Lifeward has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market. Comparatively, SkyAI, Inc. Common Stock has a beta of 2.06, meaning that its share price is 106% more volatile than the broader market.

Lifeward has higher revenue and earnings than SkyAI, Inc. Common Stock. SkyAI, Inc. Common Stock is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lifeward	$20.92M	0.99	-$19.91M	-$19.66	N/A
SkyAI, Inc. Common Stock	$200K	270.85	-$282.50M	-$1.63	N/A

In the previous week, Lifeward had 2 more articles in the media than SkyAI, Inc. Common Stock. MarketBeat recorded 2 mentions for Lifeward and 0 mentions for SkyAI, Inc. Common Stock. Lifeward's average media sentiment score of 2.00 beat SkyAI, Inc. Common Stock's score of 1.74 indicating that Lifeward is being referred to more favorably in the media.

Company	Overall Sentiment
Lifeward	Very Positive
SkyAI, Inc. Common Stock	Very Positive

26.8% of Lifeward shares are held by institutional investors. Comparatively, 17.2% of SkyAI, Inc. Common Stock shares are held by institutional investors. 1.5% of Lifeward shares are held by insiders. Comparatively, 1.2% of SkyAI, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Lifeward presently has a consensus target price of $10.00, suggesting a potential upside of 35.70%. Given Lifeward's stronger consensus rating and higher probable upside, analysts plainly believe Lifeward is more favorable than SkyAI, Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lifeward	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
SkyAI, Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Lifeward beats SkyAI, Inc. Common Stock on 11 of the 16 factors compared between the two stocks.

Get Lifeward News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFWD vs. The Competition

Export

Metric	Lifeward	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$20.74M	$5.65B	$6.90B	$12.86B
Dividend Yield	N/A	1.78%	2.60%	10.00%
P/E Ratio	-0.37	23.39	280.82	25.41
Price / Sales	0.99	43.83	599.65	90.78
Price / Cash	N/A	32.60	72.11	49.40
Price / Book	1.33	6.03	12.95	6.08
Net Income	-$19.91M	$151.74M	$3.49B	$348.07M
7 Day Performance	3.79%	4.81%	3.57%	4.71%
1 Month Performance	-8.12%	-0.15%	-2.50%	-2.12%
1 Year Performance	-12.90%	8.50%	73.94%	20.58%

Lifeward Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFWD Lifeward	2.4337 of 5 stars	$7.37 +2.2%	$10.00 +35.7%	-13.5%	$20.74M	$20.92M	N/A	60	News Coverage Positive News Analyst Upgrade
NRXS NeurAxis	2.2067 of 5 stars	$6.24 -4.5%	$13.00 +108.4%	+178.2%	$77.34M	$4.28M	N/A	19	News Coverage
LNSR LENSAR	1.2444 of 5 stars	$5.23 -2.3%	$10.00 +91.4%	-56.9%	$64.16M	$58.44M	N/A	110	Upcoming Earnings
NNOX Nano-X Imaging	3.7258 of 5 stars	$0.92 +4.8%	$4.00 +334.8%	-77.5%	$64.10M	$13.02M	N/A	190	Trending News Upcoming Earnings
DXR Daxor	1.5192 of 5 stars	$10.89 +2.2%	N/A	+7.4%	$63.57M	N/A	N/A	37	Positive News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFWD) was last updated on 8/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lifeward (LFWD) Competitors